Background. Clinical and experimental evidence suggest that haemodialysis (HD) procedure is an inflammatory process. For the production of proinflammatory lipid mediators in many inflammatory reactions, the release of arachidonic acid by phospholipase A 2 (PLA 2 ) enzyme is a prerequisite. Therefore, the purpose of the present investigation was to establish whether the activity of PLA 2 increases during HD and whether the increase depends on the type of dialyser used. Methods. We performed dialysis in eight chronic HD patients. Blood samples entering and leaving the dialyser were obtained before and at 15, 60, 120 and 180 min after the dialysis was started, on one occasion using a cuprophane and on another occasion a cellulose triacetate dialyser. PLA 2 activity was assessed in crude plasma and in plasma extract. Results. PLA 2 activity in plasma extract exhibited similar biochemical properties to that of inflammatory human synovial fluid PLA 2 enzyme which is of group II PLA 2 . PLA 2 activity in crude plasma represents a type of PLA 2 other than the synovial type. In HD patients, baseline PLA 2 activities in crude plasma and plasma extract were significantly increased when compared to normal subjects. An increase in PLA 2 activity was observed in crude plasma with a peak appearing at 15 min when the patients were dialysed with cuprophane and cellulose triacetate membranes. This increase was observed in both arterial and venous blood samples and was more pronounced when the patients were dialysed with cuprophane than with cellulose triacetate membranes. When PLA 2 was assessed in plasma extract, the activity increased only with cuprophane but not with cellulose triacetate membranes. Conclusion. PLA 2 activity in plasma is increased in HD patients and increases during the dialysis procedure to a greater extent with a less biocompatible membrane. Continuous activation of PLA 2 might be relevant for long-term deleterious consequences of HD.